Related studies have shown that oxidative stress and PGC1α-mediated mitochondrial dysfunction are involved in the pathological changes of NAFLD lipid metabolism caused by SIRT1 silencing in type 2 diabetes mellitus [111]. This evidence concerns the gene PPARGC1A and metabolic dysfunction-associated steatotic liver disease.